STOCK TITAN
  1. Home
  2. Sec-filings
  3. DNLI
  4. [144] Denali Therapeutics Inc. SEC Filing

Denali officer plans sale of 2,768 shares

Denali Therapeutics Inc. (DNLI) is the issuer for a planned sale of common stock reported under Rule 144 on behalf of officer Alexander Schuth.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Denali Therapeutics Inc. (DNLI) is the issuer for a planned sale of common stock reported under Rule 144 on behalf of officer Alexander Schuth. The notice covers 2,768 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an approximate aggregate market value of $65,767.68 as referenced. The shares relate to Restricted Stock Units with an acquisition date of 08/09/2026, and the proposed sale date is 09/01/2026 on NASDAQ.

Positive

  • None.

Negative

  • None.
Shares to be sold 2,768 shares of common stock Planned sale under Rule 144 by officer Alexander Schuth
Approximate aggregate market value $65,767.68 Referenced for the 2,768 shares covered by the Form 144
CUSIP/identifier 55934378 Numeric identifier associated with the common stock entry
Proposed sale date 09/01/2026 Date for sale of common shares on NASDAQ
Acquisition date of RSUs 08/09/2026 Acquisition date for Restricted Stock Units related to the shares
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Units financial
"Common | 08/09/2026 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
NASDAQ market
"09/01/2026 | NASDAQ"
The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

What does the Form 144 filing involving DNLI disclose?
It discloses that officer Alexander Schuth has filed a Rule 144 notice for a proposed sale of 2,768 shares of Denali Therapeutics Inc. common stock, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 09/01/2026.

How many DNLI shares are covered by Alexander Schuth’s Form 144?
The Form 144 notice covers 2,768 shares of Denali Therapeutics Inc. common stock. These shares are associated with Restricted Stock Units with an acquisition date of 08/09/2026.

What is the approximate value of the DNLI shares in this Form 144?
The filing references an approximate aggregate market value of $65,767.68 for the 2,768 shares of Denali Therapeutics Inc. common stock covered by the Rule 144 notice.

When are the DNLI shares expected to be sold under this Form 144?
The proposed sale date stated in the Form 144 is 09/01/2026. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

What type of DNLI securities are involved in this Form 144 filing?
The securities are common stock of Denali Therapeutics Inc., tied to Restricted Stock Units with an acquisition date of 08/09/2026, for which a proposed sale of 2,768 shares has been noticed under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR